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Abstract
In the scenario of real-time monitoring of hospital patients, high-quality inference of pa-
tients’ health status using all information available from clinical covariates and lab tests is
essential to enable successful medical interventions and improve patient outcomes. Devel-
oping a computational framework that can learn from observational large-scale electronic
health records (EHRs) and make accurate real-time predictions is a critical step. In this
work, we develop and explore a Bayesian nonparametric model based on Gaussian process
(GP) regression for hospital patient monitoring. We propose MedGP, a statistical frame-
work that incorporates 24 clinical and lab covariates and supports a rich reference data
set from which relationships between observed covariates may be inferred and exploited for
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high-quality inference of patient state over time. To do this, we develop a highly structured
sparse GP kernel to enable tractable computation over tens of thousands of time points
while estimating correlations among clinical covariates, patients, and periodicity in patient
observations. MedGP has a number of benefits over current methods, including (i) not
requiring an alignment of the time series data, (ii) quantifying confidence regions in the
predictions, (iii) exploiting a vast and rich database of patients, and (iv) inferring inter-
pretable relationships among clinical covariates. We evaluate and compare results from
MedGP on the task of online prediction for three patient subgroups from two medical data
sets across 8,043 patients. We found MedGP improves online prediction over baseline meth-
ods for nearly all covariates across different disease subgroups and studies. The publicly
available code is at https://github.com/bee-hive/MedGP.
Keywords: Gaussian processes, electronic health records, sparse time series analysis,
spectral mixture kernel, kernel density estimation.
1. Introduction
Large-scale collections of electronic health records (EHRs) are becoming useful for under-
standing disease progress, early diagnosis, and personalized treatments for many clinical
diseases (Murdoch and Detsky, 2013; Hripcsak and Albers, 2013; Ghassemi et al., 2015a).
EHRs contain rich patient information—disease history, demographics, vital signs, and lab
results—that clinicians use to diagnose and treat patients. In this work, we are interested
in developing a statistical framework that leverages medical data from a set of reference pa-
tients to enable personalized, real-time monitoring of new hospital patients. In particular,
we consider data from the Hospitals at the University of Pennsylvania (HUP) containing
hospital information for over 260, 000 patients, and the public Multiparameter Intelligent
Monitoring in Intensive Care (MIMIC-III) data set with more than 53, 000 admissions from
38, 000 patients in intensive care units (ICUs) (Johnson et al., 2016).
One motivation for monitoring new patients is to characterize patient state to allow
the early diagnosis of sepsis or septic shock. Sepsis is one of the leading causes of death
in critically ill patients in the United States (Hotchkiss and Karl, 2003). Each year an
estimated 750,000 cases of sepsis or septic shock occur in the US. The mortality rate of septic
patients ranges from 20% to 30%, and accounts for roughly 9.3% of all US deaths (Angus
et al., 2001; Kumar et al., 2011). Sepsis is usually developed during a patient’s stay in the
hospital. However, accurate diagnosis of sepsis is difficult due to heterogeneous symptoms
across patients (Pierrakos and Vincent, 2010).
One way to reduce the mortality rate of sepsis is to increase the accuracy of early
diagnosis of sepsis. To do this, we might develop a model of patient state and fit this
model to EHR data from previous hospital patients with sepsis. However, existing EHR
data pose several challenges because they have been collected with traditional monitoring
methods. Many of the covariates, lab results in particular, are sparsely sampled across
patients. That is, there are only a small number of observations of any lab result per
patient. For example, vital signs are generally taken once every three to four hours for
inpatient data, and once every hour for patients in the intensive care unit (ICU). In contrast,
blood tests requiring a blood draw are generally performed at most once a day. We see this
sparsity in an example of 24 clinical covariates (Table 1) measured across time for a single
patient, including four densely sampled vital signs (respiration rate, heart rate, systolic
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Type Covariate Sepsis Neoplasms Heart Failure MIMIC-III
Vital Respiration rate (RR) 87,076 493,964 147,445 291,466
Vital Heart rate (HR) 96,317 527,989 227,951 294,746
Vital Systolic blood pressure (SBP) 84,909 447,666 104,129 124,587
Vital Body temperature (Temp) 80,597 364,286 94,468 56,533
Lab Blood urea nitrogen (BUN) 12,528 71,825 21,751 25,102
Lab Carbon dioxide (CO2) 12,672 72,784 21,844 20,979
Lab Calcium level 10,388 66,051 18,867 20,568
Lab Chloride 10,100 68,534 21,421 26,248
Lab Creatinine 12,689 72,928 21,889 25,237
Lab Glucose point-of-care (Glucose POC) 20,444 170,872 54,239 24,196
Lab Hematocrit (Hct) 12,752 74,060 22,035 24,810
Lab Hemoglobin (Hgb) 13,005 75,646 27,891 21,226
Lab Mean cell hemoglobin (MCH) 12,587 69,736 18,379 20,877
Lab Mean cell hemoglobin concentration (MCHC) 12,577 69,682 18,359 20,885
Lab Mean cell volume (MCV) 12,587 69,751 18,380 20,875
Lab International normalization ratio (INR) 5,733 38,810 17,005 15,735
Lab Prothrombin time (PT) 5,722 38,844 17,007 15,734
Lab Partial thromboplastin time (PTT) 5,872 41,894 19,596 17,185
Lab Platelet 12,586 69,945 18,367 21,395
Lab Potassium level 12,830 77,395 28,470 27,200
Lab Red blood cell (RBC) 12,600 69,776 18,387 20,876
Lab Red cell distribution width (RDW) 12,580 69,757 18,381 20,877
Lab Sodium level 12,848 78,617 28,597 26,383
Lab White blood cell (WBC) 12,581 69,950 18,384 20,960
Table 1: The 24 clinical covariates modeled in MedGP. This table includes the total
number of observations for each covariate across patients in three disease groups—
sepsis, neoplasms, and heart failure—in the HUP data, and the heart failure pa-
tients in the MIMIC-III data.
blood pressure, and body temperature) and 20 sparsely sampled lab covariates (Figure 1).
Data missingness is systematic and not at random (Newgard and Lewis, 2015): a doctor will
only order a test that will be informative in characterizing patient state relevant to diagnosis.
Moreover, these time series data are not aligned across patients to a reference time point
or disease onset; instead, patient intake is at time 0 and release is hours or days later. The
sparsity over patients and uncalibrated time series make the physiological progression of
disease within patients or joint analysis of time series across patients challenging due to
substantial uncertainty of patient state and rate of disease progression at any time.
In this work, we build a statistical framework that uses sparse, heterogeneous EHR time
series data to monitor and predict vital signs and lab results for each patient in an online
way. To do this, we first designed a nonparametric model based on Gaussian process (GP)
multivariate regression to explore the correlations both within each clinical covariate across
time and across clinical covariates given rich EHR reference data. Our model includes
a highly structured GP kernel regularized using sparsity-inducing priors to avoid overfit-
ting, allow interpretability, and ensure computational tractability. Second, we propose a
framework based on nonparametric density estimation to tailor the empirical model to a
patient-specific model for each new patient. For real-time monitoring, we update the empir-
3
0 10 20 30 40 50
C
h
lo
ri
d
e
C
a
lc
iu
m
0 10 20 30 40 50
C
O
2
0 10 20 30 40 50
B
U
N
0 10 20 30 40 50
T
e
m
p
e
ra
tu
re
0 10 20 30 40 50
S
B
P
0 10 20 30 40 50
H
R
0 10 20 30 40 50
R
R
0 10 20 30 40 50
0 10 20 30 40 50
IN
R
0 10 20 30 40 50
M
C
V
0 10 20 30 40 50
M
C
H
C
0 10 20 30 40 50
M
C
H
0 10 20 30 40 50H
e
m
o
g
lo
b
in
0 10 20 30 40 50H
e
m
a
to
c
ri
t 0 10 20 30 40 50
G
lu
c
o
s
e
0 10 20 30 40 50C
re
a
ti
n
in
e
0 10 20 30 40 50
W
B
C
0 10 20 30 40 50
S
o
d
iu
m
0 10 20 30 40 50
R
D
W
0 10 20 30 40 50
R
B
C
0 10 20 30 40 50P
o
ta
s
s
iu
m
0 10 20 30 40 50
P
la
te
le
t
0 10 20 30 40 50
P
T
T
0 10 20 30 40 50
P
T
Elapsed Time (day) Elapsed Time (day)
Figure 1: An example of time series data of 24 clinical covariates for a septic pa-
tient in the HUP data. The 24 covariates include four vital signs—respiration
rate (RR), heart rate (HR), systolic blood pressure (SBP), body temperature—
and 20 lab results. The time series are aligned by the patient’s admission time.
The density of sampling varies widely over the 24 covariates. A full description
of these covariates can be found in Table 1.
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ical distribution from reference patients with patient-specific observations as measurements
are observed. We evaluate our method, MedGP, on over 6,000 patients from three disease
groups with more than four million measurements from the HUP data and one disease group
from the MIMIC-III data set. We compare results to state-of-the-art approaches for patient
online monitoring and investigate differences in correlations among covariates across disease
groups.
2. Related Work
Related work falls into three areas of medical time series analysis: (i) incorporating noisy,
heterogeneous, irregular, and sparsely sampled time series data; (ii) combining information
across multiple time series; and (iii) exploiting reference data in addition to observations
about the current patient to enable patient-specific predictions for a new hospital patient.
Most prior work has focused on modeling each clinical covariate separately. Due to the
irregularity and temporal sparsity of medical data, conventional time series models, such
as hidden Markov models (HMMs), autoregressive (AR) models, state-space models, and
linear dynamical systems (LDS), are challenging to apply because of the assumption of
regular measurement sampling in time. Recent work has focused on developing methods to
compensate for the missing data in order to work with models that assume complete data.
In Kim et al. (2010), missing data were imputed by averaging over a time window using a
kernel support vector machine (SVM). Methods such as matrix factorization and k-nearest
neighbor (KNN) clustering were used for missing data imputation, and improvements in sep-
tic shock prediction were reported (Ho et al., 2014). In other work, a hierarchical switching
LDS model was used to monitor the physiological signals during neonatal sepsis; the model
allows the latent state of a patient to change during periods with fewer observations (Stan-
culescu et al., 2014). In an alternative approach, noisy and sparse time series data were
smoothed temporally by putting Gaussian priors on the mean parameters of the Gaussian
mixture model, which is related to a Gaussian process prior, although the distribution is
over a finite-dimensional vector (Marlin et al., 2012).
Gaussian processes (GPs) are useful approaches for time series analysis because they can
naturally capture irregular time series observations and estimate prediction uncertainties
in a probabilistic framework (Roberts et al., 2012). For these reasons, GPs have been
applied to the analysis of medical time series data. Previous work used a single-output
GP regression model to smooth and impute each covariate independently (Stegle et al.,
2008; Lasko et al., 2013). The Probabilistic Subtyping Model (PSM) added patient-specific
information for smoothing temporal trajectories of clinical covariates and clustering disease
subtypes (Schulam et al., 2015). PSM learns a mixture model based on a B-spline and GPs
to impute the clinical measurements for patients with scleroderma. Demographic covariates,
including gender, ethnicity, and clinical history, were also incorporated in the model. In
an extension of PSM, the authors adapted patient-specific information to forecast specific
clinical covariates (Schulam and Saria, 2015); the time series for each covariate was still
modeled independently.
The idea of capturing the joint dynamics between vital signs and lab tests has also been
explored. Using high-frequency regularly sampled time series, the dynamics between heart
rate (HR) and blood pressure (BP) were modeled using a mixture of an LDS model (Nemati
5
et al., 2012) and a switching vector autoregressive model (SVAR) (Lehman et al., 2015).
The joint dynamics estimated across covariates were reported to be associated with hos-
pital mortality. In other work (Rizopoulos and Ghosh, 2011), a multivariate spline-based
approach with linear mixed effects was used to predict multiple longitudinal outcomes and
time-to-death of patients. Time series graphical models (TGMs) (Dahlhaus, 2000; Tank
et al., 2015) have also been studied and applied for analyzing multivariate medical time
series of ICU patients (Gather et al., 2002). TGMs model the partial correlations between
each dimension of the multivariate time series as an undirected graph. However, both TGMs
and SVAR models follow the assumptions of vector autoregressive (VAR) models, and thus
assume the sampling interval of the time series is fixed across dimensions. In practice, this
means missing data imputation needs to be done in advance (Tank et al., 2015).
Several multi-output GP frameworks have been proposed for other application areas.
In the geostatistics literature, the linear model of coregionalization (LMC) characterizes
correlations between outputs through a set of kernels and coregionalization matrices that
estimate weights for pairwise outputs (Journel and Huijbregts, 1978; Goovaerts, 1997).
In the machine learning literature, related models include multi-task GPs (Bonilla et al.,
2008), semiparametric latent factor models (Teh et al., 2005), and multi-task kernel learn-
ing (Titsias and La´zaro-Gredilla, 2011). These can be viewed as variations of the LMC
with different parameterizations and constraints. Convolution processes (CPs) have also
been adapted to model multiple correlated outputs through the convolution of smooth ker-
nels and latent processes (A´lvarez and Lawrence, 2011). This approach usually has fewer
hyperparameters and more efficient computation as compared to LMC, but only squared
exponential (SE) kernels have been shown to be computationally tractable. Applying a
multi-task GP (MTGP) framework (Bonilla et al., 2008) to clinical time series analysis has
also been considered in two studies (Ghassemi et al., 2015b; Du¨richen et al., 2015); both
studies considered one patient as one task and used the remaining patients as reference
training data. Other work adapted the LMC framework with one SE kernel to model three
sparsely sampled clinical covariates (intracranial pressure, mean arterial blood pressure,
and Pressure-Reactivity Index) jointly (Ghassemi et al., 2015b). The MTGP was shown to
outperform a single-task GP (STGP) in prediction error. Both MTGP and CP have also
been used with an SE kernel to model three densely sampled vital signs (respiration rate,
systolic blood pressure, and heart rate); both methods showed improvements as compared
to a single-task GP (Du¨richen et al., 2015).
Our work is distinct from previous research in several ways. First, we use the GP
regression framework to model multiple irregularly sampled medical time series using a
sparse structured multi-output kernel. In contrast to related work (Ghassemi et al., 2015b;
Du¨richen et al., 2015), our kernel uses a mixture of flexible spectral kernels (Wilson and
Adams, 2013), allowing periodic behavior and both short-term and long-term dependencies
within and across the clinical covariates over time. Second, we use the LMC framework to
enable an interpretable quantification of cross-correlation and sparsity between covariates.
Third, we model many more clinical covariates (24) compared with previous studies (at
most three); in the online medical setting, efficient and scalable computation in this multi-
view model is essential. To the best of our knowledge, this is the first work that uses a
sparse and low-rank formulation of the shared covariance matrix across clinical covariates
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to estimate and regularize the relationships between covariates in order to learn about
covariate relationships specific to patient subgroups and to prevent overfitting.
In our methodology, MedGP, we trained a GP model on each reference patient sep-
arately, and used these models to estimate the empirical population-level model using
nonparametric density estimation. This approach avoids training procedures that iter-
ate through all reference patients, which is computationally intractable for an online sys-
tem (Ghassemi et al., 2015b; Du¨richen et al., 2015). To speed up training, we optimized the
implementation in C++ using multithreading. Finally, in order to personalize the model
for a new patient, we update the empirical population-level model on-the-fly to estimate
patient specific parameters as measurements from the new patient are observed.
3. Methods
In this section, we describe our method, MedGP, for estimating the underlying dynamic
processes jointly across a large number of sparsely sampled clinical covariates. We first
describe the design of the Gaussian process kernel for capturing the temporal correlations
within and between covariates. Next, we introduce the sparsity-inducing prior to regularize
the LMC weight matrix. We then describe estimation of the parameters in the prior and
the kernel. Next, we describe how to learn a patient-specific kernel by first building a
population-level model from reference patients and then performing online updating of
the parameters when observations about a new patient accumulate. Finally, we describe
methods to perform computationally tractable online inference in these models, concluding
with a discussion of computational complexity.
3.1 Gaussian Processes (GPs)
Gaussian processes (GPs) are distributions over arbitrary functions. By definition, a Gaus-
sian process is a collection of random variables, any finite collection of which have a joint
Gaussian distribution. Alternatively, a GP can be described as a distribution on an arbi-
trary function, defined as
f(x) ∼ GP(m(x), κ(x,x′)), (1)
where m(x) is the mean function:
m(x) = E[f(x)], (2)
and κ(x,x′) is the covariance function or kernel :
κ(x,x′) = E[(f(x)−m(x))(f(x′)−m(x′))]. (3)
Any finite number of function values jointly have a multivariate Gaussian distribution with
mean vector µ and covariance matrix K between any pair of observations, defined by the
kernel function,
[f(x1), f(x2), · · · , f(xT )]> ∼ N (µ,K),
µ = [m(x1),m(x2), · · · ,m(xT )]>,
Ki,j = κ(xi, xj).
(4)
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Properties of the function f(x) such as smoothness or periodicity are determined by the
kernel function κ(x,x′). One of the most commonly used kernels is the squared exponential
(SE) kernel
κ(x,x′) = σ2 exp
(
−||x− x
′||2
2`2
)
, (5)
which is parameterized by a length scale ` and a scale factor σ. The functions generated
by a GP with an SE kernel are smooth because the kernel function is infinitely differen-
tiable (Rasmussen and Williams, 2006). The value of the length scale ` determines the
distribution of changes over the function value with respect to changes in the input x, en-
couraging a specific smoothness. Due to its simplicity, SE is used in many applications;
however, the properties of the functions that it captures are fairly limited. Periodic func-
tions, for example, are not well modeled by an SE kernel, but instead captured by a periodic
kernel
κ(x,x′) = σ2 exp
−4 sin2
(
pi||x−x′||
p
)
`2
, (6)
where p is the period of the function. When modeling medical time series, the SE kernel or
the periodic kernel are often used in combination to capture the unknown source-specific
smoothness and periodicity of the trajectories of clinical covariates (Stegle et al., 2008;
Du¨richen et al., 2015).
3.2 Gaussian Process Regression with a Structured Multi-Output Kernel
Our first goal is to jointly model multiple clinical covariates—vital signs and lab tests—over
time for each patient using GP regression. For the ith patient, we denote the time series of
the dth covariate as a vector xi,d, representing the time points that the dth covariate was
observed, and the corresponding observation vector yi,d:
x>i,d =
[
xi,d,1, xi,d,2, . . . xi,d,t . . . , xi,d,Ti,d
]
, (7)
y>i,d =
[
yi,d,1, yi,d,2, . . . yi,d,t . . . , yi,d,Ti,d
]
, (8)
where t indexes time, and Ti,d is the total number of observations for the dth covariate of
the ith patient.
To represent the time series data over all D covariates, we define
x>i =
[
x>i,1,x
>
i,2, . . . ,x
>
i,D
]
, (9)
y>i =
[
y>i,1,y
>
i,2, . . . ,y
>
i,D
]
, (10)
where xi,yi ∈ RTi×1, Ti =
(∑D
d=1 Ti,d
)
. Let Fi be a multi-output function over time for
the ith patient. We capture the relationship between time and clinical observations as a
GP regression model:
yi = Fi(xi) + i, (11)
where i is the residual noise vector. Marginally at the tth observation of the dth covariate,
the residual noise is modeled as
i,d,t ∼ N (0, σ2i,d), (12)
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where σ2i,d is the covariate-specific residual variance for each individual.
We assume that the function Fi is drawn from a patient-specific Gaussian process GP i
with mean function µi(x) and kernel κi(x,x
′):
Fi ∼ GP i(µi(x), κi(x,x′)). (13)
We set µi(x) = 0 (Rasmussen and Williams, 2006).
We designed the kernel κi(x,x
′) to capture predictive and generalizable covariance struc-
ture across medical time series data. Assuming the covariates are correlated across time, we
adapted the linear model of coregionalization (LMC) framework (Journel and Huijbregts,
1978; Goovaerts, 1997). We used a set of Q basis kernels {κq(x,x′)}Qq=1 to model D covari-
ates jointly. The kernel for the cross-covariance of any pair of covariate types is modeled by
a weighted, structured linear mixture of the Q basis kernels. The full joint kernel is written
as a block structured function
κi(xi,x
′
i) =
Q∑
q=1


bq,(1,1)κq(xi,1,x
′
i,1) · · · bq,(1,D)κq(xi,1,x′i,D)
bq,(2,1)κq(xi,2,x
′
i,1) · · ·
...
...
. . .
...
bq,(D,1)κq(xi,D,x
′
i,1) · · · bq,(D,D)κq(xi,D,x′i,D)

 , (14)
where bq,(d,d′) scales the covariance (defined by the qth basis kernel) between covariates d
and d′, and κi(xi,xi) ∈ RTi×Ti . We collapsed bq,(d,d′) into a set of weight matrices {Bq}Qq=1,
where each Bq is a symmetric positive definite matrix
Bq =

bq,(1,1) bq,(1,2) · · · bq,(1,D)
bq,(1,1)
...
. . .
...
...
...
. . .
...
bq,(D,1) bq,(D,2) · · · bq,(D,D)
 ∈ RD×D. (15)
If the inputs are the same for all covariates, we can further simplify Eq. (14) with Kronecker
product ⊗. That is, if xi,1 = xi,2 = · · · = xi,D , xi,∗ and x′i,1 = x′i,2 = · · · = x′i,D , x′i,∗ :
κi(xi,x
′
i) =
Q∑
q=1
Bq ⊗ κq(xi,∗,x′i,∗), (16)
although in practice we do not often see this situation in medical time series data.
The properties of the time series observations, such as periodicity and short term de-
pendencies, are captured in the Q basis kernels. For medical covariates, the properties of
each patent’s time series observations may vary. As a trivial example, when a patient is
under age 18, their pulse will be well correlated with their age, height, and weight; above
age 18, the correlation among pulse, age, height, and weight is more variable within age
than across ages. Furthermore, only a few vital signs, such as heart rate, blood pressure,
and body temperature, are known to be periodic with a 24-hour period (i.e., a circadian
rhythm), but whether there is a similar period for specific lab results, such as white blood
cell count or pressure of carbon dioxide in the blood, is unclear (Widmaier et al., 2004).
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To handle the heterogeneity of patterns within covariates and across patients, we se-
lected the spectral mixture (SM) kernel as the basis kernel (Wilson and Adams, 2013).
The SM kernel is a general form of a variety of stationary kernels, including the squared
exponential (SE) kernel and the periodic kernel, and has also shown good performance
in modeling processes generated from more complex kernels through a mixture of kernels
approach (Wilson and Adams, 2013). The basis kernel κq(xt, xt′) is written as
κq(xt, xt′) = exp (−2pi2τ2vq) cos (2piτµq),
τ = |xt − xt′ | (absolute distance in time). (17)
In our work, the mixture weights for each basis kernel are encoded in Bq.
To be used for GP regression, κi(x,x
′) must be a valid Mercer kernel, i.e., the Gram
matrix must be positive definite for all x and x′. Since the matrix produced by each basis
kernel κq(x,x
′) is symmetric positive definite, we only need to ensure that every Bq is
positive definite to produce a Mercer kernel. To do this, we parameterized Bq as
Bq = AqA
>
q +

λq,1 0 · · · 0
0 λq,2 · · · 0
...
...
. . .
...
0 0 · · · λq,D
 = AqA>q + diag(λq), (18)
Aq =
aq,(1,1) · · · aq,(1,Rq)... . . . ...
aq,(D,1) · · · aq,(D,Rq).
 (19)
Here Aq ∈ RD×Rq , λq ∈ RD×1. We let Rq denote the number of non-zero columns in Aq,
or the rank for Bq when λq = 0.
For any two observations from the same patient of different covariates at different times,
denoted as xi,d,t and xi,d′,t′ , the prior covariance from the GP kernel is
κi(xi,d,t, xi,d′,t′) =
Q∑
q=1
bq,(d,d′)κq(xt, xt′). (20)
We summarize the parameters and hyperparameters of our SM-LMC kernel in Table 2.
3.3 Sparsity-Inducing Priors on Weight Matrix Bq
As the number of medical covariates included in the model increases, we need to increase the
number of basis kernels Q and corresponding Rq to allow greater representational flexibility.
However, too many basis kernels may lead to overfitting and will become computationally
intractable. To avoid this, we regularized the elements of each weight matrix Bq by intro-
ducing structured sparsity-inducing priors on each Aq matrix as follows.
We included two layers of sparsity-inducing priors for flexible, data-adaptive shrinkage
behavior, modified from previous work (Polson and Scott, 2010; Gao et al., 2013). First,
we put column-wise sparsity-inducing priors to regularize each column in Aq. This corre-
sponds to regularizing the degree of freedom of the functions, or number of latent processes
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notation size description
vq Q squared exponential part of qth basis kernel
µq Q periodicity of qth basis kernel
aq,(d,r)
∑Q
q=1D ×Rq weights of (d, d′) for qth basis kernel
λq,(d) Q×D intra-covariate weights of the dth covariate for qth basis kernel
Bq = AqA
>
q + diag(λq)
Table 2: The list of hyperparameters for modeling the d = 1 : D clinical variables and
q = 1 : Q mixture kernels.
generated from each basis kernel in the LMC model (A´lvarez et al., 2012). Second, we
put sparsity-inducing priors on each matrix element aq,(d,r) in Aq to produce element-wise
sparsity. The effect of element-wise sparsity is to perform model selection on the number
of basis kernels that each pair of covariates uses for covariance representation. Finally, we
put sparsity-inducing priors on the elements of λq to shrink the covariance for observations
from the same covariate.
In practice, we implemented each layer of the prior as a two-layer hierarchical gamma
distribution. The generative model is written as
τq,(r) ∼ Gamma(d, η),
φq,(r) ∼ Gamma(γ, τq,(r)),
δq,(d,r) ∼ Gamma(β, φq,(r)),
ψq,(d,r) ∼ Gamma(α, δq,(d,r)),
aq,(d,r) ∼ N (0, ψq,(d,r)),
(21)
where each element aq,(d,r) has a Gaussian distribution. Parameters φq,(r) and τq,(r) control
the column-specific shrinkage, while parameters ψq,(d,r) and δq,(d,r) control the local shrink-
age of each element in the Aq matrix. For vector λq, we regularized each element with a
local Laplace prior:
λq,(d) ∼ Laplace(0, βλ). (22)
For our results, we set α = β = γ = d = 0.5 to recapitulate two layers of the horseshoe
prior, using a statistically equivalent prior represented by a hierarchical gamma with four
layers (Carvalho et al., 2010; Armagan et al., 2011; Gao et al., 2013; Zhao et al., 2016).
Parameters ψq,(d,r), δq,(d,r), φq,(r), and τq,(r) were estimated during optimization. We set
βλ = 0.01 to regularize the diagonal terms λq,(d). The hyperparameter η controls the
overall shrinkage profile of the hierarchical gamma prior (see Appendix A for more details).
We chose η over {0.01, 0.1, 1.0} using cross-validation prediction error. Hyperparameter η
was chosen using grid search over the range {0.01, 0.1, 1.0} using cross-validation prediction
error as the objective.
3.4 Parameter Learning
To estimate the parameters for the regularized kernel, we optimized the posterior proba-
bility. We denote all parameters that were estimated directly as θ and hyperparameters in
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the sparsity-inducing prior as θf :
θ =
{
µq, vq, aq,(d,r), λq,(d), ψq,(d,r), δq,(d,r), φq,(r), τq,(r)
}
,
for q = 1, · · · , Q d = 1, · · · , D r|q = 1, · · · , Rq (23)
θf = {α, β, γ, d, η, βλ} ,
α = β = γ = d = 0.5.
(24)
The posterior density of our model is then
p(θ|y,x,θf ) ∝ p(y|x,θ)p(θ|θf )
∝ p(y|x,θ)
 Q∏
q=1
D∏
d=1
Rq∏
r=1
p(aq,(d,r)|ψq,(d,r))p(ψq,(d,r)|α, δq,(d,r))p(δq,(d,r)|β, φq,(r))

×
 Q∏
q=1
Rq∏
r=1
p(φq,(r)|γ, τq,(r))p(τq,(r)|d, η)
 Q∏
q=1
D∏
d=1
p(λq,(d)|βλ)
 Q∏
q=1
p(vq)p(µq)
 .
(25)
The term p(y|x,θ) is found by calculating the GP marginal likelihood given the values of
θ (Rasmussen and Williams, 2006), which is
log p(y|x,θ) = −1
2
y>(K|θ + I)−1y −
1
2
log |K|θ + I| −
(∑D
d=1 Ti,d
2
)
log (2pi). (26)
We thus estimated θ by solving the optimization problem:
arg max
θ
log p(θ|y,x,θf ) = arg max
θ
Q(θ). (27)
See Eq. (31) in Appendix B for the derivation of Q(θ).
Due to the conjugacy of the hierarchical gamma priors, we optimized parameters ψq,(d,r),
δq,(d,r), φq,(r), τq,(r) directly using maximum a posteriori (MAP) estimates of their posterior
distribution (or mean when the mode does not exist). Our optimization procedure then
consists of two parts. In the first part, we used the update equations to estimate ψq,(d,r),
δq,(d,r), φq,(r), and τq,(r) directly. In the second part, we estimated parameters µq, vq,
aq,(d,r), and λq,(d,r) using a scaled conjugate gradient method to find the local maximum,
conditioned on ψˆq,(d,r), δˆq,(d,r), φˆq,(r), and τˆq,(r). (Details can be found in Appendix B
Eq. (32)–(35) and Eq. (36)–(40).) We iterated over the two steps until the change in Q(θ)
reached the convergence criterion (< 0.005) or until the maximum number of iterations
(≥ 30).
3.5 Estimating the Population-Level Model and Online Updating
The GP with the structured kernel described above lets us model the patient-specific joint
dynamics between covariates within the same patient. We now describe how we built a
population-level empirical prior from a set of mixture kernels estimated from all training
patients, and how we apply this empirical prior to a new patient.
To estimate the empirical priors across reference patients, we trained one GP kernel for
each patient separately, and then we clustered and extracted the distribution of the basis
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Figure 2: Illustrations of the basis kernels and the features for kernel clustering.
(a) An example of a discrete set of basis kernels with different µ and v within a
72-hour window. (b) An example of the 72-dim temporal features (shown with
red dots) taken from a kernel for GMM clustering.
kernels (defined by hyperparameters µq and vq). The idea here is that, when we observe
a set of estimated mixture kernels, we would like to understand the high-level properties
of these mixture kernels shared across covariates and patients in the same patient group,
and then estimate the distributions of these hyperparameters through observations of basis
kernels belonging to this cluster. For instance, a circadian rhythm (24-hour periodicity)
may be observed in some covariates for some patients, but the period across patients could
vary within a range. Across the space of µ and v the spectral kernels vary substantially
(Figure 2a). For each basis kernel that was estimated, the characteristic period is 1/µq
and the length scale is 1/2pi√vq (Wilson and Adams, 2013). There are different ways to
define the features of a kernel. Here we used the temporal features of the learned kernels
directly (Figure 2b). The temporal spacing of two adjacent points is one hour, and we use
the kernel values within a window of length 72 hours. We then used a Gaussian mixture
model (GMM) model to perform clustering on the kernels, and we chose the best number
of kernel clusters Q′ (1 ≤ Q′ ≤ Q) based on Bayesian information criterion (BIC). For the
MedGP implementation, we adapted the open source scikit-learn package (Pedregosa et al.,
2011). We used version 0.18.1, with ten random restarts, a maximum of 2,000 iterations,
and allowing each mixture component to have its own covariance matrix.
For each identified kernel cluster, we estimated one set of parameters µq and vq for the
basis kernel, and the weight coefficients—elements in Bq matrices, computed using the Aq
matrices and λq vectors. We do this by building an empirical distribution using kernel
density estimation (KDE) with a Gaussian kernel over the GP kernel hyperparameters
assigned to that cluster. The bandwidth of the kernel density estimator was chosen based
on Silverman’s “rule-of-thumb” (Silverman, 1986). We estimated each new parameter using
density weighted means with the density from the univariate KDE as the weights. Note
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that if there were multiple kernels in a patient cluster, the estimated Bq matrices were
added based on the additive assumption of our kernel before aggregating to estimate the
population-level kernel for that cluster. To allow online updating, we estimated the elements
of the new empirical Aq matrix and λq vector corresponding to each new Bq matrix using
singular value decomposition (SVD). For the univariate GP regression, we did not use
density weighted means because we found them to be unstable; instead we used a grid-
based search to identify the hyperparameters with the highest kernel density estimates.
As the number of vital signs and lab measurements of a new patient accumulate, we
update the hyperparameters to estimate a patient-specific kernel. Indeed, we update the
kernel sequentially every time a new observation arrives. To do this in a computationally
tractable way, we used the momentum method (Rumelhart et al., 1988) with a 72-hour
window of previous observations to update the kernel hyperparameters when predicting the
value of next observation. For all experiments, we chose the momentum as 0.9 and the
learning rate as 10−5. For elements in the Aq matrices, we do not update the values if the
elements were regularized to be zero so as to maintain the empirical sparsity structure.
3.6 Efficient Inference in MedGP
The main bottleneck of our method is in learning patient-specific kernel hyperparameters.
Let Ti =
∑D
d=1 Ti,d denote the total number of samples of the ith patient; the computational
cost to compute the Gram matrix is O(QT 2i ), which increases linearly with the chosen
number of basis kernels. To find the MAP estimates of the parameters, we need to invert
and compute the determinant of the Gram matrix (K|θ+I) in Eq. (26). The computational
complexity for the full matrix inversion is O(T 3i ) using Cholesky decomposition. When
calculating the gradients for optimizing the hyperparameters, the cost is dominated by
O(QDRT 2i ) after the inverse Gram matrix is pre-computed, which is linear with the total
number of the kernel hyperparameters. In practice, the complexity of each iteration is
either O(T 3i ) or O(QDRT 2i ). That is, the patient with the most measurements is the
main bottleneck for training. In our implementation, we mitigate the bottleneck using
optimized linear algebra functions in Intel MKL library with multithreading and computing
the gradients of the hyperparameters in parallel.
3.7 Medical Data Preprocessing
The HUP medical time series data consist of electronic health records (EHRs) from more
than 260,000 patients admitted to a University of Pennsylvania Hospital. For each patient,
the data include many heterogeneous clinical covariates, including ICD-9 codes, patient
demography, length-of-stay, vital signs, and lab results. We jointly modeled the 24 covariates
with the greatest number of observations across patients (Table 1). We selected three groups
of discharged patients from these data: 1,365 septic patients, 952 patients with heart failure,
and 4,723 patients with neoplasms. Each patient has at least one observation for each of
the 24 covariates, and in total over four million observations were evaluated.
For each clinical covariate, we first removed obvious artifacts (e.g., values outside of
the possible range in living humans). For the patients with neoplasms or heart failure,
we used the full patient length-of-stay in training and testing. For septic patients, the
disease progression varies substantially across patients, and the distribution of the covariates
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changes dramatically depending on the disease phase. To address this issue, we segmented
the time series data into four disjoint partitions based on clinical status: no sepsis, pre-
sepsis, sepsis, and recovery. To label each stage, we incorporated prior clinical domain
knowledge. For instance, we identified sepsis stages using ICD-9 codes and positive blood
culture results. Since our model assumes stationarity, to better estimate the temporal
correlation across covariates, we chose the recovery stage before the patients’ discharge to
test our method, since this is a relatively stable stage. We used the bed unit information to
identify if the patient is in a stable state. That is, when a patient is transferred to step-down
bed, we labeled the time series after the transfer as recovery. The median length-of-stay
after pre-processing is 140 hours for the sepsis group, 285 hours for the heart failure group,
and 197 hours for the neoplasms group.
We applied similar preprocessing procedure to the MIMIC-III data. We selected patients
with a heart failure diagnosis that eventually had a routine discharge. We removed artifacts
such as out of bounds values for each covariate, and applied the criteria to each patient that
at least five measurements were taken for all 24 selected covariates. We extracted 1,004
heart failure under these criteria and used 1,003 of them, excluding one patient with more
than 50K measurements due to memory constraints.
3.8 Experimental Setup
We applied MedGP to the three selected groups of patients separately, and evaluated char-
acteristics and performance of MedGP under two different experimental settings. In the
first analysis, we evaluated the model’s ability to learn the covariance between a pair of
highly correlated clinical covariates, and we measured the imputation performance in an
online setting. In the second analysis, we follow the same online setting, but instead jointly
model all 24 clinical covariates, including four vital signs and 20 lab covariates. In both
settings, we evaluated our method using 10-fold cross-validation at the patient level. That
is, for each fold we ran the kernel clustering step on the kernels from the training patients
to estimate a set of population-level basis kernels and Bq matrices. This set of kernels was
then applied to the held-out patients to predict the value of each covariate using obser-
vations from all other covariates measured at the same time as, or earlier than, the test
observation (i.e., no future information included). After each prediction, we updated the
patient-specific kernel parameters using the new observations from the test patient.
We compared our method to several univariate methods that modeled each covariate
separately: (i) a naive one-lag prediction procedure, which predicts an observation equal to
the last observation available from the same patient; (ii) an independent GP with squared
exponential (SE) or spectral mixture (SM) kernels fitting each covariate separately (we
tested with Q = 1 for SM); (iii) the multi-resolution Probability Subtyping Model (PSM)
combining linear regression, B-splines, and independent GPs (Schulam et al., 2015). To
estimate the spectral kernel parameters, for each patient we initialized 1, 000 random kernels
by drawing uniformly from a length scale range (between 6 and 72 hours) and period range
(between 24 and 72 hours). We computed the marginal likelihood of all random kernels for
each patient, and then initialize optimization using the kernels with the highest marginal
likelihood. The elements in the Aq matrices are initialized randomly between −1.5 and 1.5.
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We compared results from MedGP to these various methods using two metrics: (i)
mean absolute error (MAE) of the predicted observations with the true observations, and
(ii) 95% coverage, the percentage of true observations that fell within the predictive 95%
confidence region. We quantified and reported the improvements with respect to both
metrics compared to all three baselines (naive prediction, univariate GP, and PSM). To test
if the differences in prediction results from different approaches were statistically significant,
we performed paired t-tests for the results of each covariate and compared the p-values with
a Bonferroni corrected threshold (dependent on the number of jointly modeled covariates
in each experiment).
We note that the original PSM was designed to model scleroderma disease (Schulam
et al., 2015). Thus, to make it applicable to our different patient groups, several adjustments
were made. First, we omitted the population and environmental factors selected for their
relevance to scleroderma. Second, we chose the knots of the B-spline basis by sampling
every hour for vital signs and every 24 hours for lab results between zero and the longest
length-of-stay for patients in each disease group. Third, to make PSM training feasible on
the scale of our data set, we limited the maximum number of subtypes to ten for the sepsis
and heart failure groups, and 20 for the neoplasms group.
4. Experimental Results
We analyzed the performance of the method, MedGP—multi-output GP with a sparse SM-
LMC kernel and online updating—by applying it to time series data from the Hospital of
the University of Pennsylvania (HUP) and the public MIMIC-III data set (Johnson et al.,
2016). We ran two types of experiments—one on two correlated lab covariates and the
other with 24 covariates jointly. The results were compared against the baseline methods
for prediction accuracy and 95% coverage calibration.
4.1 Results of Two Lab Covariates
As a proof of principle, we jointly modeled two well correlated lab covariates, prothrombin
time (PT) and international normalization ratio (INR) on three HUP subgroups. PT mea-
sures the time it takes for the plasma in the blood to clot, and is often ordered to check
bleeding problems. INR is an international standard for PT to account for possible vari-
ations across different labs. For the same patient, the two covariates usually have similar
trajectories over time (Figure 1).
We trained the kernels for one patient’s INR and PT time series data both with and
without the structured sparse prior (Figure 3). Both Aq and Bq matrices estimated using
the sparse prior have higher levels of sparsity versus those estimated without using the sparse
prior. We observed that for both methods, one of the estimated basis kernels κ1 captures
long-term (around one month) dependencies. However, with the sparse prior, the estimated
weights associated with this long term kernel A1 are rank one instead of rank two. This
means the trajectories of the two covariates are similar enough to be explained by one instead
of two functions, and thus fewer hyperparameters. Moreover, two basis kernels were found
with zeros weights A2 and A5 (Figure 3b), suggesting that the prespecified number of basis
kernels may be reduced. We also found that the off-diagonal elements in the Bq matrices
in both cases have nonzero values, suggesting a nonzero covariance between PT and INR
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Figure 3: The trained kernel for one patient jointly modeling PT and INR. For
both the (a) SM-LMC kernel and (b) sparse SM-LMC kernel, the Aq matrices
(upper row), Bq matrices (middle row), and the basis kernel κq (bottom row) are
illustrated. The zero elements are colored in light grey. Here l.c denotes length
scale for each basis kernel, and per. denotes period. The length-of-stay for this
patient was over 90 days.
observations. In particular, two basis kernels captured the covariance between PT and INR:
one with a greater than one-month trend (Figure 3b, B1 and κ1), and one with a 27-hour
trend (Figure 3b, B4 and κ4). Here, the sparse kernel has 18 non-zero hyperparameters,
whereas there are 40 for the non-sparse kernel. We can compare the two fitted kernels using
both log marginal likelihoods and model selection scores. The log marginal likelihoods of
the two kernels are −118.16 (SM-LMC) and −128.50 (sparse SM-LMC), indicating a better
fit for the SM-LMC model without sparsity. However, the Bayesian information criterion
(BIC) values, which take into account the number of parameters in a model, were 353.63
(SM-LMC) and 309.79 (sparse SM-LMC), where values closer to zero reflect better models.
Thus, using a sparse prior has the advantage of a more compact kernel representation.
We then ran our model on all three disease groups separately, and compared our method
with the univariate baselines described in Section 3.8 under the scenario of online imputation
of the same two well-correlated clinical covariates. For independent GPs, we used gradient
descent to optimize the hyperparameters. For PSM, we performed grid search for the
parameters of the B-spline and the independent GP kernel. For our method, we set Q = 5
and Rq = 2 for the Aq matrices for training. In the sepsis and heart failure groups, three
nonzero basis kernel functions (Q′ = 3) were found for the model using the SM-LMC kernel,
while only two nonzero basis kernel functions (Q′ = 2) were found using the sparse SM-
LMC kernel; the number of nonzero hyperparameters were 18 and 12 respectively. In the
neoplasms group, the number of nonzero basis kernels were the same as the pre-specified
number (Q′ = Q = 5). With 10-fold cross-validation, we found that results using the
SM-LMC kernel showed smaller imputation error than those using the baselines for both
PT and INR (Figure 4). The mean absolute errors (MAEs) showed that the non-sparse
SM-LMC kernels perform imputation the best among the related approaches. On the other
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Figure 4: The results of prediction when jointly modeling INR and PT. The figure
illustrates (a) mean absolute error (MAE), and (b) 95% coverage (the dashed red
line indicates 95%). The error bars denote ±1 standard error.
hand, looking at the 95% coverage, results using non-sparse or sparse SM-LMC kernel
were well calibrated with respect to the confidence region compared with independent GPs,
although sometimes slightly worse than PSM. Note that in this experiment we used a p-
value threshold p < 0.005 to detect statistical significance, which reflects the Bonferroni
correction. The results indicate that the sparse prior finds models with sparse structure
while maintaining prediction performance in this two covariate case.
4.2 Results of a Joint Model Including 24 Vital Signs and Lab Covariates
In the second experimental setting, we jointly modeled 24 vital signs and clinical covariates
(D = 24) for all three disease groups (Table 1). We set the number of basis kernels Q = 5
and the number of nonzero columns in Aq as Rq = 8 in this experiment for the three HUP
subsets. For the MIMIC-III heart failure subset, we set Q = 4. More detailed results of
the best setup as well as the results with different Q could be found in Appendix C and
Appendix D.
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4.2.1 Estimating Population-Level Kernels
We first visualized the population-level kernels estimated from the three patient groups of
the HUP data (Figure 5–7) and the MIMIC-III patient subgroup (Figure 8). We observed
shared patterns in the basis kernels κq and the weight matrices Bq across all patient groups.
Comparing the estimated population-level kernels, we found at least one long-term smooth-
ing basis kernel with length scale longer than three days, and one 24- to 25-hour periodic
basis kernel, which indicates the existence of circadian rhythms in specific covariates as
expected. Furthermore, in the neoplasms group, which consists of more patients than the
other two groups, we found additional short-term smoothing basis kernels and one 12- to
13-hour periodic basis kernel, which may correspond to known circasemidian rhythm of
clinical covariates, such as body temperature. We also observed an 11-hour periodic kernel
in the MIMIC-III subset.
In addition to the characteristics of the basis kernels, our model with the sparse prior
also showed interpretable cross-covariate patterns (Figure 5b, Figure 6b, and Figure 7b
and Figure 8b). Based on the Bq matrices, we identified groups of well correlated co-
variates. For instance, lab covariates hematocrit (Hct), hemoglobin (Hgb), and red blood
cell (RBC) count showed the highest levels of correlation. Since both Hct and Hgb are
known to be proportional to the number of red blood cells, this positive correlation was
encouraging (Widmaier et al., 2004). The pair of lab covariates studied in the previous
section, INR and PT, also showed substantial positive correlation. We found that the four
vital signs—respiration rate (RR), heart rate (HR), systolic blood pressure (SBP), and
body temperature (Temp)—had substantial correlations with each other as well as weak
correlations with some lab covariates. Another identifiable set of well-correlated covari-
ates includes lab measurements of carbon dioxide (CO2), calcium, chloride, potassium, and
sodium. The three lab covariates related to the concentration of hemoglobin—mean cell
hemoglobin (MCH), mean cell volume (MCV), and mean cell hemoglobin concentration
(MCHC)—appeared to have substantial correlation (Figure 5). The correlations modeled
in these covariance matrices are exploited for accurate prediction and imputation in the
MedGP framework.
To learn more about the importance of each kernel type across all subsets, we visualized
the percent coverage of each type of kernel clusters found in all the subsets we have worked
on (Figure 9). The coverage of each kernel type is computed as the ratio of patients that
have non-zeroBq matrix corresponding to it. We found that the kernel clusters of long-term
(length scale > 3 days) and short-term (length scale < 12 hours) smooth dependencies have
the highest coverage across four subsets. In the MIMIC-III subset, the coverages of the
short-term kernel, and the 12-hour and 24-hour periodic kernels are higher than that of in
the HUP subsets. We think this is because the higher sampling frequency in the MIMIC-III
subset enables more accurate estimation of the short-term and periodic dependencies.
4.2.2 Results for Online Imputation
Next, we used the trained kernels to perform online imputation for each patient subgroup,
where the goal is to predict the next observation for each covariate given the observations
at previous time points. Across these methods, we used the percentage of improvement
in MAE over three types of baselines—naive prediction, univariate GP (with SE or SM
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Figure 5: The estimated population-level basis kernels and corresponding Bq ma-
trices for septic patients. We show the kernels estimated (a) without a sparse
prior (Q′ = 3) and (b) with a sparse prior (Q′ = 3). The sparsity of the Bq ma-
trices is calculated as the percentage of nearly zero entries (i.e., values ≤ 10−3).
The units for length scale or period are (d) for days and (h) for hours.
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Figure 6: The estimated population-level basis kernels and corresponding Bq ma-
trices for patients with heart failure. We show the kernels estimated (a)
without a sparse prior (Q′ = 4) and (b) with a sparse prior (Q′ = 4). The spar-
sity of the Bq matrices are calculated as the percentage of nearly zero entries
(i.e., values ≤ 10−3). The units for length scale or period are (d) for days and
(h) for hours.
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Figure 7: The estimated population-level basis kernels and corresponding Bq ma-
trices for patients with neoplasms. We show the kernels estimated (a) with-
out a sparse prior (Q′ = 5) and (b) with a sparse prior (Q′ = 5). The sparsity
of the Bq matrices are calculated as the percentage of nearly zero entries (i.e.,
values ≤ 10−3). The units for length scale or period are (d) for days and (h) for
hours.
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Figure 8: The estimated population-level basis kernels and corresponding Bq ma-
trices for 1003 patients with heart failure in MIMIC-III data set. We
show the kernels estimated (a) without a sparse prior (Q′ = 4) and (b) with a
sparse prior (Q′ = 4). The sparsity of the Bq matrices is calculated as the per-
centage of nearly zero entries (i.e., values ≤ 10−3). The units for length scale or
period are (d) for days and (h) for hours.
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Figure 9: The coverage over subject for each discovered kernel. We illustrated the
proportion of subjects that have non-zero B matrix of a kernel that is in the same
cluster of the population-level kernel clusters.
kernel), and PSM—to compare results for each of the 24 clinical covariates; we visualized
the results separately (Figure 10–12; Figure 14–17 in Appendix C; Figure 18–33 in Appendix
D). We also show the results of variations of our method for comparison (with or without
the proposed sparse prior; with or without online updating). We performed paired t-tests
on predictions from MedGP and each baseline to quantify the improvements, and statistical
significance was evaluated using Bonferroni-corrected p < 4.17× 10−4.
Comparing results with the independent GP model—specifically, selecting the best re-
sults from the SE or SM kernel, we found that MedGP, and in particular sparse SM-LMC
with online updating, outperformed the independent GP model on the online imputation
task for most covariates across the four patient groups (Figure 10). In the HUP data, we
found 18, 21, 22 covariates significantly improved by MedGP in the sepsis, heart failure, and
neoplasms subgroups respectively. In the MIMIC-III subset, we found 19 covariates were
improved. For all four groups, the number of covariates that were improved significantly by
MedGP is greater than using SM-LMC kernels without the sparse prior. We found that the
covariates that were well correlated in Bq usually showed significant positive improvements
over independent GPs; Hct, Hgb, and RBC are notable examples. Similar observations
could be made for INR and PT, the pair of lab covariates studied previously (Figure 4).
Across 24 covariates, the MAEs for INR and PT were slightly worse compared with only
modeling these two covariates. However, we also observed that using the sparse prior with
the SM-LMC kernel led to better performance as compared to not using the sparse prior,
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Figure 10: The percent improvement using MedGP for online imputation com-
pared to independent (unvariate) GPs. The figures depicts the results of
24 covariates for the (a) sepsis, (b) heart failure, and (c) neoplasms and (d)
MIMIC-III heart failure subgroups. The y-axis is on log scale. The error bars
denote ±1 standard error. The ? indicates statistical significance.
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Figure 11: The percent improvement using MedGP for online imputation com-
pared to the naive method. The figures depicts the results of 24 covariates
for the (a) sepsis, (b) heart failure, and (c) neoplasms and (d) MIMIC-III heart
failure subgroups. The y-axis is on log scale. The error bars denote ±1 standard
error. The ? indicates statistical significance.
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Figure 12: The percent improvement using MedGP for online imputation com-
pared to PSM. The figure depicts the results of 24 covariates for the (a) sepsis,
(b) heart failure, and (c) neoplasms and (d) MIMIC-III heart failure subgroups.
The y-axis is on log scale. The error bars denote ±1 standard error. The ?
indicates statistical significance.
27
indicating that sparse regularization is helpful when jointly modeling heterogeneous co-
variates. Finally, there were some covariates for which MedGP did not improvement over
univariate GPs in two or more disease groups, including red cell distribution width (RDW),
white blood cell count (WBC) and platelets.
When the baseline method is the naive one-lag method, for all three disease groups,
we found fewer covariates with significant improvements compared with improvements over
univariate GPs (Figure 11). In particular, the covariates for which the naive method had
an advantage were lab covariates that have piece-wise linear behavior, such as mean cell
hemoglobin (MCH) and mean cell hemoglobin concentration (MCHC) (Figure 1). In the
case of piece-wise linear behavior, our kernel does not improve the performance compared
with the naive approach since the time series are neither smooth nor periodic. Moreover, we
also found that the naive method performed better in respiration rate, PTT, platelet, RDW,
and white blood cell (WBC) count. Overall, however, our method improved online predic-
tion results for 18, 20, 20 of the 24 covariates in sepsis, heart failure, and neoplasms groups,
respectively. In the MIMIC-III subset, we found 14 covariates were improved significantly
over the naive method.
When the baseline method is PSM (Schulam et al., 2015), we found that our method
outperformed PSM for most of the lab covariates, but PSM outperformed MedGP in im-
putation of vital signs and two lab covariates: glucose point-of-care (Glucose POC) and
potassium (Figure 12). For vital signs and glucose level, PSM has an advantage because of
a higher sampling rate in those covariates and the highly structured mean function in PSM
in the HUP subsets. The sampling rates are usually every 4 hours for vital signs and every
8 hours for glucose, which is more frequent than other lab covariates. Since PSM uses a
B-spline basis function to capture the empirical mean, it may tolerate non-stationarity bet-
ter. However, in the MIMIC-III subset, we observed that our method improved in imputing
glucose and three vital signs (RR, SBP, temperature) over PSM significantly. We think
this reflects the higher sampling rate of the covariates that allows better estimation of the
short-term temporal dependencies. Overall, MedGP significantly improved the imputation
of 17, 20, 18 covariates in sepsis, heart failure, neoplasms subsets respectively in the HUP
data set, and 16 covariates in the MIMIC-III subset when compared with PSM. We contrast
the PSM approach of structuring the mean function with our approach of structuring the
kernel function, which leads to different types of gains in this problem.
Next, we looked at the calibration of the 95% coverage (Figure 16 and Figure 17 in
Appendix C; Figure 26–33 in Appendix D). We found that MedGP outperformed indepen-
dent GPs in terms of calibration of the 95% confidence region for all covariates. For this
evaluation, the values closer to 95% are better. We observed that the coverage using the
non-sparse SM-LMC kernel was usually higher than the coverage using the sparse SM-LMC
kernel in the three HUP subgroups, indicating that MedGP may slightly underestimate
covariate-specific noise. In contrast, in the MIMIC-III subset, we observed that MedGP
gave consistently more accurate 95% coverage than without regularization in most covari-
ates. We also found that, in all patient subsets, online updating significantly improves the
accuracy of the 95% coverage. Among all tested methods, PSM tended to overestimate the
95% confidence region. We think this is because PSM assumes that the input time series are
aligned by patient status, and this alignment is not the case in our data. With unaligned
data, PSM learned large marginal variance parameters due to high empirical variance of
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Implementation Sequential Multithreading
Computing Gram matrix 11 2
Inverting Gram matrix 13 3
Computing gradients 2497 97
Total per iteration 2521 102
Table 3: Training time (in seconds) for a single iteration under different imple-
mentations of MedGP. The total number of observations across time for this
patient is 6,679. The sequential test used a single CPU, while the multithreading
test used 35 CPUs—one thread per CPU.
the observations across patients at the same elapsed time. In contrast, the estimation of
marginal covariance parameters in MedGP is not affected by alignment because estimates
are patient-specific. We also observed that for either MedGP or PSM, the coverage was
lower for some covariates in the MIMIC-III subset than in HUP subsets, such as temper-
ature, CO2, and PTT. This potentially reflects greater non-stationarity in the MIMIC-III
subset, whose records were from intensive care units (ICUs) instead of regular hospital beds.
Finally, we compared the prediction performance of MedGP compared with the version
without patient-specific online updating. We observed that online updating significantly
improves the imputation errors of at least 12 out of 24 covariates in sepsis, heart failure,
neoplasms, and the MIMIC-III subset (Figure 14 and Figure 15 in Appendix C; Figure 18–
25 in Appendix D). Similarly, evaluating the 95% coverage, all 24 covariates were improved
by the online updating across the three diseases groups in HUP, and 18 covariates were
improved in the MIMIC-III subset (Figure 16 and Figure 17 in Appendix C; Figure 26–33
in Appendix D). This improvement highlights the importance of updating the empirical
priors with patient-specific observations for this problem.
4.3 Computational Efficiency and Scalability
In this section, we compare computational speed between different implementations of our
method. For patients with only a few observations, an existing implementation using con-
ventional GP inference is sufficient for computationally tractable online inference. However,
since our data include a large number of patients with potentially thousands of observa-
tions each, we implemented an exact inference algorithm in C++ and optimized it through
Intel MKL libraries and customized multithreading blocks. In the experimental setting of
Q = 5, D = 24, and Rq = 8, there are 1114 hyperparameters to estimate. We summarized
the runtime under different implementations for one patient with 2,028 unique time points
and 6,679 observations (Table 3); the tests were performed using a machine with Intel(R)
Xeon(R) CPUs running at 2.40GHz. Using our optimized implementation, for patients with
large number of observations (Ti ≥ 5000), we accelerated training by a factor of 10 to 25
on average as compared with the sequential approach. We also compared our implementa-
tion with the standard GPy (GPy, since 2012) implementation under different sample sizes
and Q, and reached empirically at least three times speed up. We provide these results in
Appendix E.
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The proposed framework can be parallelized at the patient level and is suitable for
analysis when patient data are observed in a streaming form. For each reference patient, we
distributed the optimized training process on a computing cluster to estimate the patient-
specific hyperparameters in parallel. In addition, the population-level kernels could be
updated sequentially; the computationally expensive GP training procedure does not need
to be applied to patient data in bulk. That is, when we receive more data from new patients,
we only need to update the kernel density estimators. Our framework provides better
computational efficiency compared to models designed for smaller collections of observations
(e.g., approximately two hundred observations for each patient) as in most previous work.
Those approaches are computationally intractable when working on a set of rich patient
observations of the magnitude of the HUP data due to large matrix inversions and summing
marginal likelihoods across patients at each iteration.
5. Discussion
In this paper, we propose a flexible and efficient framework for estimating the temporal
dependencies across multiple sparse and irregularly sampled medical time series data. We
developed a model with multi-output Gaussian process regression with a highly structured
kernel. We fit this model using an optimized implementation of exact GP inference to three
different disease groups in the HUP medical data set and the MIMIC-III ICU data set. We
showed that our method, MedGP, improves performance for online prediction of 24 clinical
covariates as compared with independent univariate GPs, a naive method of propagating
the previous observation, and an earlier state-of-the-art approach, PSM (Schulam et al.,
2015). We found that, for well-correlated covariates, our method improves online impu-
tation performance substantially over the related methods in most tested covariates. The
improvements over the naive one-lag prediction and univariate GPs were significant in both
vital signs and lab covariates. We found that PSM was, in general, better at predicting vi-
tal signs with more densely sampled observations. However, our approach does not require
patient time series alignment and shows better calibration of the 95% confidence region as
compared to PSM.
There are several directions that will be explored using the MedGP framework motivated
by the present results. The first direction is to allow time-varying covariances by specifi-
cally modeling non-stationarity. Some possible approaches to explore include incorporating
state-space models or change point detection (Adams and MacKay, 2007; Saatc¸i et al.,
2010), and extending those methods to work on multivariate scenarios. Another direction
of interest is to consider latent subpopulation-level structured kernels through multivariate
medical time series. We expect that our results could be further improved through incor-
porating hierarchical methods with proper features or metrics to represent the differences
between patients within the same disease group and across disease groups more carefully.
For instance, the original PSM used three levels of hierarchy based on the subpopulations of
patients with scleroderma, including population level, subpopulation level, and individual
level. Our model may benefit from such an approach, but more efficient inference procedures
are needed to train on our large data set (Feinberg et al., 2017). We should point out that
this is possible through, for instance, deriving corresponding stochastic variation inference
(SVI) algorithm. For example, previous work develops the SVI algorithm for semiparamet-
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ric latent factor model (SLFM) with Rq = 1 (Nguyen and Bonilla, 2014), which could be
generalized to apply to MedGP.
For future applications, we will use the framework to monitor the health status of pa-
tients in a hospital setting and identify those patients at high risk for acute diseases in order
to assist with decision making in treatment plans. Specifically, MedGP can impute latent
state in patients at any time point, including confidence region around those estimates;
this latent state can be used for a number of downstream analyses which require complete
knowledge of patient state at specific time points. For instance, the changes of dynamics
and temporal correlations between two vital signs have been found to be useful for disease
detection given high-frequency regularly sampled time series (Nemati et al., 2012; Lehman
et al., 2015). We demonstrated that MedGP accurately estimates the temporal correlations
in the presence of sparse, unaligned time series data for up to 24 covariates, and we would
expect to further associate the cross-covariate dynamics to more complicated diseases, such
as septic shock (Henry et al., 2015), where the interactions of multiple covariates are jointly
taken into consideration for diagnosis.
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Appendix A. Details of the Hierarchical Gamma Prior
In this appendix, we provide more background and visualization for the hierarchical gamma
prior we used for regularization. For the convenience, we use Γ(·) to denote the gamma
function, and G(a, b) to represent a gamma distribution with shape parameter a and rate
parameter b.
Following Proposition 1 in Armagan et al. (2011), for a random variable x drawn from
a normal distribution with two-layered gamma priors on variance
x ∼ N (0, ψ1), ψ1 ∼ G(α, δ), δ ∼ G(β, ν), (28)
is equivalent to the hierararchy
x ∼ N (0, 1/ρ− 1), ρ ∼ T PB(α, β, ν), (29)
where T PB(α, β, ν) denotes the three-parameter beta distribution. The probability density
function of ρ is given as
f(ρ;α, β, ν) =
Γ(α+ β)
Γ(α)Γ(β)
νβρβ−1(1− ρ)α−1[1 + (ν − 1)ρ]−(α+β). (30)
In Figure 13, we visualized the density of ρ in Equation (29) for α = β = 0.5, and under
different values of ν (Armagan et al., 2011). In this case, the prior distribution of x is equiv-
alent to a horseshoe prior, and ρ can be interpreted as the shrinkage coefficient (Carvalho
et al., 2010).
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Figure 13: The density of ρ drawn from a three parameter beta prior with dif-
ferent values of ν. For all values of ν, we set α = β = 0.5.
Specifically, for the case with four layers of gamma prior used in our work,
x ∼ N (0, ψ2), ψ2 ∼ G(α, δ), δ ∼ G(β, φ), φ ∼ G(γ, τ), τ ∼ G(d, η),
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is equivalent to
x ∼ N (0, 1/ρ− 1), ρ ∼ T PB(α, β, 1/ζ − 1), ζ ∼ T PB(γ, d, η).
In our case, we set α = β = γ = d = 0.5 so both ρ and ζ recapitulate horseshoe priors (Ar-
magan et al., 2011; Gao et al., 2013; Zhao et al., 2016).
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Appendix B. Details of Gradient Computation and Update Equations
In this appendix, the equations for the objective function during optimization, update
equations for the parameters in the sparsity inducing prior and the gradients for the hyper-
parameters of the GP kernel are listed as reference.
The objective function to optimize for training one patient, Q(θ), is
Q(θ) ∝
[
−1
2
y>(K|θ + I)−1y −
1
2
log |K|θ + I| −
(∑D
d=1 Ti,d
2
)
log 2pi
]
+
Q∑
q=1
D∑
d=1
Rq∑
r=1
(
−1
2
logψq,(d,r) −
a2q,(d,r)
2ψq,(d,r)
)
+
Q∑
q=1
D∑
d=1
Rq∑
r=1
[
α log δq,(d,r) + (α− 1) logψq,(d,r) − δq,(d,r)ψq,(d,r)
]
+
Q∑
q=1
D∑
d=1
Rq∑
r=1
[
β log φq,(r) + (β − 1) log δq,(d,r) − φq,(r)δq,(d,r)
]
+
Q∑
q=1
Rq∑
r=1
[
γ log τq,(r) + (γ − 1) log φq,(r) − τq,(r)φq,(r)
]
+
Q∑
q=1
Rq∑
r=1
(
d log η + (d− 1) log τq,(r) − ητq,(r)
)
+
Q∑
q=1
D∑
d=1
(
− log 2βλ −
|λq,(d)|
βλ
)
.
(31)
For update equations, we quoted from Zhao et al. (2016):
ψˆq,(d,r) =
(2α− 3) +
√
(2α− 3)2 + 8a2q,(d,r)δq,(d,r)
4δq,(d,r)
(32)
δˆq,(d,r) =
α+ β
ψq,(d,r) + φq,(r)
(33)
φˆq,(r) =
Dβ + γ − 1∑D
d=1 δq,(d,r) + τq,(r)
(34)
τˆq,(r) =
γ + d
φq,(r) + η
(35)
∂
∂θj
log p(y|x,θ) = 1
2
tr
((
αα> −K−1|θ
) ∂K|θ
∂θj
)
where α = K−1|θ y, θj ∈ θ (36)
34
∂Q(θ)
∂aq,(d,r)
=
1
2
tr
((
αα> −K−1|θ
) ∂K|θ
∂aq,(d,r)
)
− aq,(d,r)
ψq,(d,r)
,
where
∂K|θ
∂aq,(d,r)
= B′q ⊗ kq(x,x′),
B′q,(i,j) =

2aq,(d,r) , for i = j = d,
aq,(j,r) , for i = d, j 6= d,
aq,(i,r) , for i 6= d, j = d,
0 , otherwise.
(37)
For partial gradients used for optimization:
∂Q(θ)
∂λq,(d)
=
1
2
tr
((
αα> −K−1|θ
) ∂K|θ
∂λq,(d)
)
− sign(λq,(d))
βλ
,
where
∂K|θ
∂λq,(d)
= diag
(
λ′q
)⊗ kq(x,x′),
λ′q,(i) =
{
1 , for i = d,
0 , otherwise.
(38)
∂Q(θ)
∂vq
=
1
2
tr
((
αα> −K−1|θ
) ∂K|θ
∂vq
)
,
where
∂K|θ
∂vq
= Bq ⊗ kqv(x,x′),
kqv(x,x
′) = −2pi2τ2 exp(−2pi2τ2vq) cos(2piτµq).
(39)
∂Q(θ)
∂µq
=
1
2
tr
((
αα> −K−1|θ
) ∂K|θ
∂µq
)
,
where
∂K|θ
∂µq
= Bq ⊗ kqµ(x,x′),
kqµ(x,x
′) = −2piτ exp (−2pi2τ2vq) sin (2piτµq).
(40)
35
Appendix C. Detailed Results of Imputation Error and 95% Coverage
We organized the detailed results of online imputation on all 24 covariates under the best
number of basis kernel (Q = 5 for HUP subsets and Q = 4 for the MIMIC-III subset) in
Figure 14 to Figure 17. For Figure 14 and Figure 15, the mean absolute errors (MAEs) for
each covariate is shown (in the original unit of measure). In Figure 16 and Figure 17, we
showed the percentage for the prediction lied within the 95% confidence region (i.e. 95%
coverage). We put markers in the figures to indicate the best among all methods, and the
comparison of MedGP (sparse SM-LMC with online updating) against other methods. The
statistical significance were tested using paired t-tests on patient-level results.
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best (significant / not significant against second best)/
Sparse SM-LMC (w/ update) statistically significantly improved against
   naive method /   univariate GP (SE or SM) /   PSM /   Sparse SM-LMC (w/o update) 
Figure 14: Mean absolute error (MAE) for 12 out of 24 covariates tested. The
error bars denote ±1 standard error.
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best (significant / not significant against second best)/
Sparse SM-LMC (w/ update) statistically significantly improved against
   naive method /   univariate GP (SE or SM) /   PSM /   Sparse SM-LMC (w/o update) 
Figure 15: Mean absolute error (MAE) for 12 out of 24 covariates tested. The
error bars denote ±1 standard error.
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best (significant / not significant against second best)/
Sparse SM-LMC (w/ update) statistically significantly improved against
   univariate GP (SE or SM) /   PSM /   Sparse SM-LMC (w/o update) 
Figure 16: The 95% coverage for 12 out of 24 covariates tested. The error bars
denote ±1 standard error. The red dashed line indicates 95%.
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best (significant / not significant against second best)/
Sparse SM-LMC (w/ update) statistically significantly improved against
   univariate GP (SE or SM) /   PSM /   Sparse SM-LMC (w/o update) 
Figure 17: The 95% coverage for 12 out of 24 covariates tested. The error bars
denote ±1 standard error. The red dashed line indicates 95%.
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Appendix D. Results under Different Number of Basis Kernels
In this appendix, we showed more detailed results of the experiments using different number
of basis kernels. We ran experiments with for Q = 1, · · · , 5 on all four subsets. The results
include all three subgroups in the HUP data set and the MIMIC-III heart failure subset.
We visualized the results in Figure 18–33. We noticed that for most of the covariates,
the imputation performance (both MAE and 95% coverage) improves as the number of
Q increases. We also observed that the best number of Q varies across covariates under
different metrics. For instance, for lab covariates INR and PT, we observed that setting
Q = 1 or Q = 2 reduces MAE compared with Q = 5, but the coverage still improves after
Q = 2. Allowing more numbers of basis kernels increases the flexibility for customization,
but also increases complexity and thus the risk of overfitting for some covariates or patients.
Overall Q = 5 for HUP subsets and Q = 4 for the MIMIC-III subset reached the largest
number of covariates improved over the best of baselines using imputation error as the
performance metric. How to improve the performance for a specific clinical covariate at
patient-level would be one future direction of interest.
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Figure 18: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 19: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 20: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 21: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 22: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 23: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 24: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 25: The mean absolute error (MAE) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error.
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Figure 26: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 27: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 28: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 29: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 30: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 31: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 32: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Figure 33: The 95% coverage (in percentage) of online imputation under different
Q for all cohorts. The error bars denote ±1 standard error. The red dashed
line indicates 95%.
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Appendix E. Improvements in Empirical Runtime
In this appendix, we provide the comparisons in runtime with GPy (GPy, since 2012),
a state-of-the-art optimized Python library for GPs. We selected few benchmark cases
from the MIMIC-III subset, and profiled the runtime for performing one iteration when
using gradient-based optimizers. That is, the runtime for computing the gram matrix, log
marginal likelihood, and gradients of all parameters. The experiments were performed on
the machine with 20 Intel(R) Xeon(R) CPUs running at 2.50GHz (no GPUs were used). For
GPy implementation, we also allowed multithreading and the access to MKL optimization
for matrix operations, provided by Anaconda with academic license. In Figure 34, we show
the average runtime for a single iteration under different number of basis kernels: Q = 1
and Q = 5, corresponding to 242 and 1114 parameters (D = 24, R = 8). We found that for
training cases smaller than 104 observations, GPy with multithreading is comparable to our
implementation. However, for the cases larger than 104 observations, our implementation
speeds up by up to 2.5 times. The largest case we tested here includes 29,525 observations.
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Figure 34: The empirical runtime of our implementation. A comparison of the aver-
age runtimes for one iteration (including computation of gradients) for MedGP
and optimized baseline GPy.
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